Cargando…
Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
BACKGROUND: Studies have suggested that the serum creatinine/cystatin C (Cr/CysC) ratio is a surrogate marker for muscle wasting is associated with adverse outcomes in several disease conditions. To clarify the utility of the Cr/CysC ratio as a prognostic marker in chronic kidney disease (CKD) we ev...
Autores principales: | Hyun, Young Youl, Lee, Kyu-Beck, Kim, Hyoungnae, Kim, Yaeni, Chung, Wookyung, Park, Hayne Cho, Han, Seung Hyeok, Oh, Yun Kyu, Park, Sue Kyung, Oh, Kook-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550211/ https://www.ncbi.nlm.nih.gov/pubmed/36225865 http://dx.doi.org/10.3389/fnut.2022.996674 |
Ejemplares similares
-
Discrepant glomerular filtration rate trends from creatinine and cystatin C in patients with chronic kidney disease: results from the KNOW-CKD cohort
por: Kang, Eunjeong, et al.
Publicado: (2020) -
Cystatin C is Better than Serum Creatinine for Estimating Glomerular Filtration Rate to Detect Osteopenia in Chronic Kidney Disease Patients
por: Kwon, Young Eun, et al.
Publicado: (2017) -
Urine creatinine concentration influences the prognostic value of proteinuria for MACE prediction from the findings of the KNOW-CKD study
por: Oh, Yun Jung, et al.
Publicado: (2022) -
Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
por: Ding, Ping’an, et al.
Publicado: (2022) -
Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
por: Shi, Shanshan, et al.
Publicado: (2022)